Monday, March 06, 2017

SeeThruEquity Issues Update on Reign Sapphire Corporation (OTCQB: $RGNP)

SeeThruEquity Issues Update on Reign Sapphire Corporation (OTCQB:  $RGNP)

NEW YORK, NY - March 6, 2017 (Investorideas.com Newswire) SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Reign Sapphire Corporation (OTCQB: RGNP)


The report is available here: RGNP Update Note.

Headquartered in Beverly Hills, CA, Reign Sapphire Corporation (OTCQB: RGNP, "Reign") is attempting to build a new premium consumer brand in the jewelry sector focused on ethically-processed, Australia-mined sapphires. The company is pursuing this with a unique approach to the supply chain supported by an intriguing technology-driven consumer marketing program. Successful execution would position Reign as what management has called the "world's first vertically integrated source to retail model" for sapphire gemstones and fine sapphire jewelry. As part of the consumer strategy, Reign plans to leverage technology acquired in a recent acquisition, as well as its supply chain, where it purchases rough commercial sapphires in bulk directly from commercial miners in Australia, and then control the supply at each step along the way to retail, enabling the company control over quality, costs and design. In our view the strategy is intriguing given what appears to be an underrepresentation of sapphires at retail in the US jewelry market – only 8% of total sales include colored gemstones and the potential financial and quality benefits that could be achieved by controlling the process from the miners-gate to retail.

Highlights from the report are as follows:

Reign to acquire Coordinates Connection, Inc.
On January 9, 2017, Reign CEO Joseph Segelman issued an update to investors in which he outlined recent developments at Reign, including the recent announcement that Reign acquired custom jewelry company Coordinates Collection, Inc. ("Coordinates Collection"), a transaction that closed on December 1, 2016. Headquartered in Los Angeles, California, Coordinates Collection is a customized jewelry company founded in 2012 by Owen Devries.
Coordinates Collection's flagship product line includes rings, bracelets, and necklaces that display the latitude and longitude of places of significance to the customer. Products are made from precious and semi-precious metals and stones, as well as ceramic coatings. Coordinates Collection is predominantly sold through online channels (90%), and also has wholesale distribution with an international retail presence in Dubai. Importantly, the deal is expected to add a differentiated technology enhancing the company's data driven approach to marketing.

Coordinates Connection adds revenue-generating platform
Reign sees a key advantage of the move to acquire Coordinates Connection as the addition of a revenue-generating, online consumer technology platform. Indeed, the acquisition provides Reign with an established online consumer sales platform, which management sees as being synergistic with Reign's mine-gate to consumer model. Coordinates Collection also brings revenues scale, with sales primarily through online sales last year, according to the acquisition announcement. Terms of the deal included the issuance of 7mn shares of Reign, and a cash payment of $500,000, contingent upon a future offering, as well as earn-out payments based on the performance of certain agreed on products.

Target unchanged at this time
We are leaving the price target for Reign unchanged at this time. Reign is still an early-stage developing company with an intriguing approach to a large market, with resulting risks and opportunities. Our expectation is that we will learn more about the company's ability to execute on revenue growth during calendar 2017.

Please review important disclosures on our website at www.seethruequity.com.


About Reign Sapphire Corporation
Based in Beverly Hills, California, Reign Sapphire Corporation (RGNP) is a fully-reporting, DTC-eligible company, originally established as a "source to retail" model for fine Australian sapphires - rough sapphires to finished jewelry, a color gemstone brand, and a jewelry brand featuring Australian sapphires.

Reign Sapphire Corporation now includes Reign Sapphires, Le Bloc Jewelry, and Coordinates Collection.

More Ways to Reign
It's not just about sapphires, but the moments the precious gemstones represent. Reign Brands focuses on elevating products into personal keepsakes that are built on quality with a unique, customized point of view.

Reign Brands
Reign Brands, including Le Bloc and Coordinates Collection, combine quality craftsmanship and timeless designs to provide a personalized shopping experience to commemorate life's most memorable moments.

About SeeThruEquity
Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed small-cap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information, visit www.seethruequity.com.

Contact:
Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Disclosure RGNP is a previous featured showcase company on Investorideas.com and previously paid for news and social media services
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Friday, March 03, 2017

Investorideas.com talks metals and mining with David Stein of Aerecura Capital Corp

Investorideas.com talks metals and mining with David Stein of Aerecura Capital Corp

Investorideas.com Delta BC, Point Roberts WA – March 3, 2017 – www.Investorideas.com, Investorideas.com talks metals and mining with David Stein of Aerecura Capital Corp.

David shares what he is seeing in the first quarter for mining and precious metal stocks and what stands out as some key factors determining the market direction.

He also discusses what types of deals he is excited about this year as an investor, noting  he is seeing more quality deal flow right now than he has in the past.

Aerecura Capital Corp was founded in 2016 to capitalize on investment opportunities in the metals, mining and natural resources sector. They identify and execute under-the-radar and underserved investment strategies and invests its own capital alongside its partners. 






About Aerecura Capital Corp
Toronto-based Aerecura was founded in 2016 to capitalize on investment opportunities in the metals, mining and natural resources sector. Aerecura identifies and executes under-the-radar and underserved investment strategies and invests its own capital alongside its partners. More info at http://www.aerecuracapital.com/

David Stein Bio:
During 7 years with Aberdeen, David spearheaded a number of important investment initiatives, generating strong returns during the last bull market, and capitalizing on opportunistic transactions during the recent downturn for natural resources. Among those many deals was the spin-out of Ore Acquisition Partners LP in 2015, a private equity mining fund that he manages today.

Prior to Aberdeen, David started his career in finance with Cormark Securities' predecessor, Sprott Securities Inc. where over 9 years he worked on both the investment banking and research teams as an Analyst, and later a Director and member of Cormark's Executive Committee. While a research analyst, David achieved a strong reputation as innovative stock-picker, and was in many cases the first analyst to pick up coverage of small and micro-cap stocks that would later be acquired or have grown to be large cap stocks on the TSX today.

Both of these phases: research analyst and investment manager; have helped David shape his mining industry network, valuation and diligence skills and transaction capability making him a leader amongst the next generation of mining finance.



About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Sectors we cover in include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow stocks in your favorite stock sector including mining stocks with Investor Ideas stock directories http://www.investorideas.com/membership/


Gold-MiningStocks.com - investing ideas in gold and mining stocks

Like Gold Stocks? View our Gold / Mining Stocks Directory


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411



This Week’s New Cannabis / Hemp Stocks Added; $KALY.V, $PURA, $MLGD, $USMJ

This Week’s New Cannabis / Hemp Stocks Added; $KALY.V, $PURA, $MLGD, $USMJ

Also Added to Investor Ideas Marijuana / Hemp List: $ADFNY, $REAC, CSE: $IAN, $QCC



Point Roberts, WA, Delta BC – March 3, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

New additions include ML Capital Group, Inc. (OTC: MLCG), North American Cannabis Holdings, Inc. (OTC: USMJ) and Puration, Inc. (OTC: PURA) who earlier this week released news : “Corporations Backing The Legalization Of Cannabis For Wellness Present Texas Teen With Commendation For Leadership And Bravery”,  telling the story of Jaren Suber and his dauntless six year battle against a rare pediatric brain cancer and his recent decision to lead the way for cancer patients everywhere by exploring the potential of cannabinol (CBD) treatment.

Others added include Kalytera Therapeutics, Inc. (TSX: KALY.V), also working with advancing CBD therapies along with companies involved in financing and management of cannabis companies, a hemp processing and growth operation firm and a company providing consumption products to the industry.

In conjunction with these additions, Investorideas.com and its cannabis related sites recently launched a new campaign to find and create the top 420 Cannabis Investor Ideas of 2017.

The Top 420 Cannabis Investor Ideas of 2017  - Investorideas.com, 420cannabisinvestorideas.com and Globalcannabisinvesting.com Launch Campaign for Finding Investing Ideas in Sector



Read the full news release for more details at http://www.investorideas.com/news/2017/marijuana/02212Top420.asp

Investor Ideas has expanded its comprehensive coverage of the space with the recent addition of the new blog, Cannabis Stock News, featuring the latest cannabis and hemp stock news from www.investorideas.com at http://cannabisstocknews.blogspot.com.



New Marijuana Companies Added:
ALGAE DYNAMICS CORP (OTCQB: ADYNF) is currently engaged in the commercialization of our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass. This biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all of which are in demand by the growing multibillion dollar food/beverage and health care sectors. Our integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our "controlled outcomes" technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil.

iAnthus Capital Holdings, Inc., (CSE: IAN)  through its 100% owned subsidiary, iAnthus Capital Management, LLC, delivers a comprehensive solution for financing and managing licensed cannabis cultivators, processors and dispensaries throughout the United States, in accordance with applicable state law. Founded by entrepreneurs with decades of experience in investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company harnesses these skills to support a diversified portfolio of cannabis industry investments for our shareholders, including direct equity investments in for-profit license holders and associated management and intellectual property holding companies, and lending facilities coupled with management services to not-for-profit license holders.

Kalytera Therapeutics, Inc. (TSX: KALY.V) is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability and short half-life. Kalytera is developing innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.

ML Capital Group, Inc. (OTC: MLCG) produces products and provides services that support the medical marijuana industry. It is producing and marketing its products and services under the Superstar Products brand name, including vapor pens, mobile applications, and books. The company offers SUPERSTAR MMJ DISPENSARIES APP, a smartphone application that provides location based on services and detailed information on medical marijuana dispensaries; SUPERSTAR VAPOR PEN, an vapor smokeless devise, which enables consumers to consume tobacco, wax, or liquid form in clean and safer manner; and SUPERSTAR MMJ RECIPE BOOK, which enables consumers to create various meals, drinks, and sweets favorites with recipe book. ML Capital Group, Inc. was founded in 2009 and is based in Fountain Hills, Arizona.

North American Cannabis Holdings, Inc. (OTC: USMJ) is founded on the core belief that cannabis makes people's lives better.  Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner.  North American Cannabis Holdings is dedicated to developing the best possible applications for cannabis to serve consumers.  North American Cannabis Holdings is introducing the AmeriCanna Café, a destination beverage company where consumers can interface with trained staff to learn about the specific benefits of cannabis and select healthy and refreshing cannabis infused beverages.  The AmeriCanna Café subsidiary is expected to enjoy a rapid rate of growth accelerated by North American’s current DuBe Hemp Energy drink distribution business and the previously announced pending acquisition of an existing, ten year old fitness café operation. The AmeriCanna Café will initially include custom blended hemp infused coffee, cold pressed juices and smoothies in addition to carrying raw hemp seeds and other hemp infused foods.  As state and federal law permits, THC infused beverages and foods will be added to the menu. North American Cannabis Holdings launched its cannabis business late in 2013 with the introduction of The American Seed & Oil Company, a subsidiary founded to conduct various pilots in the legal cannabis sector in order to explore a variety of high growth potential business opportunities. The Company will continue to develop existing and new pilot initiatives under the American Seed & Oil Company subsidiary.

Puration, Inc. (OTC: PURA) is engaged in the development of standardized and repeatable cannabis extraction processes that can deliver a consistent and high-quality concentrate for infusion into consumer food and beverage products that appeal to the recreational and wellness market segments. The Company recently released details regarding the upcoming launch of an extraction facility in the State of Colorado where the extraction process can be utilized for both the ongoing development of cannabis treatments at the same time benefiting from the extraction and selling oil from marijuana into the legal recreational market in Colorado.

REAC Group Inc. (OTC: REAC) On January 4, 2017, Real Estate Contacts, Inc. (the “Company”) closed the Asset Purchase Agreement (“APA”) with Patriot Bioenergy Corporation, a Kentucky corporation (“Patriot”), for the purchase of all of the assets related to the business of operating a hemp processing and growth operation and selling hemp related products (the “Business”).  Patriot Bioenergy Corporation is an alternative energy agriculture biofuel company specializing in the utilization of hemp.

Quadron Capital Corporation (CSE: QCC) operates through its two subsidiaries: Soma Labs Scientific Inc. (“Soma”) and Greenmantle Products Limited (“Greenmantle”), providing ancillary equipment, products and services, designed and structured to address the complex needs and requirements of cannabis industry participants in Canada and the US. Soma provides research, services and production equipment to the biotech and bioceutical industries, including cannabis extraction and processing equipment that is being leased and/or sold to various industry participants. Greenmantle’s business involves the sale of ancillary cannabis products, such as customized dispensing devices (i.e. vaporizer pens) and consumption type products such as branded encapsulation products to authorized cannabis industry participants.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

JOIN Investor Ideas

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news











This Week’s Biotech, Energy and Mining Stocks added to InvestorIdeas Directories

This Week’s Biotech, Energy and Mining Stocks added to InvestorIdeas Directories



Point Roberts, WA, Delta BC – March 3, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its investor membership, including global stock directories in biotech, energy and mining

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

The latest biotech companies include Kalytera Therapeutics, Inc. (TSX: KALY.V) which is working with advancing CBD therapies and thus crosses into our cannabis stocks list.

The newest energy company is Molori Energy Inc. (TSX: MOL.V; OTCQB: MOLOF), an oil and gas production company with current operations in the Texas Panhandle.

Both new mining companies are Canadian listed and active in lithium as well as other metals and are also now listed on our renewable energy stock list in the lithium section. Power Americas Minerals Corp. (TSX:PAM.V) (formerly Victory Ventures) has operations in South America and is included in our North American stocks doing business in Latin America – Chile, Peru, Mexico and Colombia list.


New Biotech Companies Added:
Kalytera Therapeutics, Inc. (TSX: KALY.V) is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability and short half-life. Kalytera is developing innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.

New Energy Companies Added:
Molori Energy Inc. (TSX: MOL.V; (OTCQB: MOLOF)  is an oil and gas production company with current operations in the Texas Panhandle. Founded in 2011, the experienced management team is aggressively acquiring select properties which provide immediate cash flow and development opportunities, now and in the years ahead. Molori is seizing the opportunity, in the current oil & gas environment, to assemble oil and gas production in nearby and politically safe jurisdictions. Molori is pursuing a business plan, whereby the Company either purchases producing oil and gas assets at highly attractive rates, or in some cases simply takes on existing assets by way of purchasing or assuming default notes from small regional lenders and institutions.

New Mining Companies Added:
One World Minerals Inc. (CSE:OWM) is a successful exploration and development Company with geologists having experience over the last 30 years in gold, silver, base metals and lithium.

Power Americas Minerals Corp. (TSX:PAM.V) (formerly Victory Ventures) acquisition strategy focuses on acquiring affordable, cost effective and highly regarded mineral properties in areas with proven geological potential. These areas include historical and currently producing mines with existing infrastructure. This strategy includes acquiring 100% interests in mineral properties, with no payment terms or work program commitments that would threaten a junior mining company's financial stability. The Company believes it can create maximum shareholder value efficiently and cost effectively implementing this acquisition strategy. The Company believes that the demand profile for Cobalt, Lithium, Copper, and other essential power related materials will be fundamentally led by the growing adaptation of electric vehicles, renewable energy and increased production of super alloys. With a focus on identifying and developing ethically sourced materials within the Americas, the Company intends to address the growing demand for energy metals that are being driven by innovation and the introduction of new technologies. Power Americas Minerals Corp. is a Canadian-based junior mining exploration company focused on the procurement, exploration and development of cobalt, lithium, copper and other energy metals in North and South America.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411









Thursday, March 02, 2017

Biodefense Stocks News: Aethlon Medical (NASDAQ: $AEMD) CEO Note: Bill Gates on the Threat of Bioterrorism

Biodefense Stocks News: Aethlon Medical (NASDAQ: $AEMD) CEO Note:  Bill Gates on the Threat of Bioterrorism




SAN DIEGO, CA (Investorideas Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), recently released the following note authored by its Chairman and CEO, Jim Joyce.

In a chilling address at the Munich Security Conference last Saturday, Bill Gates warned world leaders that a genetically engineered virus could kill more people than nuclear weapons. Mr. Gates expressed his concern, which is also supported by U.S. and U.K. intelligence agencies, that scientific terrorists have access to the necessary tools to design biological viruses to be weapons that could kill tens of millions of people. He also concluded that in the face of such knowledge, governments around the world remain complacent and are neither prepared nor equipped to respond to these threats.

If you are a shareholder of Aethlon Medical, you may recognize the concerns of Mr. Gates to be eerily similar to our own. As a recent example, I encourage you to review the bioterror related article that we published last year on the 21st of December.


For those dedicated to the advancement of bioterror treatment solutions, Mr. Gates is a welcome and respected voice with the visibility, influence and knowledge to recognize that therapeutic innovation will be required to counter deadly viruses created by man.

If bioterrorists were to release such a virus, I am sincerely unaware of a clinical-stage candidate beyond our Hemopurifier® that could be deployed as a post-exposure treatment countermeasure.

The void in bioterrorism treatment countermeasures is driven by a historic emphasis to align a disease-specific drug or vaccine which only targets one specific pathogen threat. Such strategies have had limited success against the breadth of threats that are known to be infectious to man and cannot be considered as a strategy to treat unknown viruses created by man.

In reality, only a fraction of the 300+ viruses known to be infectious to man are addressed with an FDA-cleared drug or vaccine.  Since 2001, our government has spent an estimated $80 billion on biodefense initiatives, yet just one of 13 viruses classified as "Category A" are addressed with an approved therapy.  "Category A" pathogens are those biological threats that pose the highest risk to national security and public health.  In addition, these types of viral pathogens maintain the potential to be genetically engineered to be used as weapons that are even more deadly and resistant than those viruses that are naturally occurring.

Our Hemopurifier® is a first-in-class medical technology currently being advanced in FDA approved studies.  In previous studies, our technology has demonstrated the ability to capture a wide range of bioterror related, pandemic, chronic and latent infectious viral pathogens.

We believe the Hemopurifier® can fulfill the broad-spectrum medical countermeasure objective of the U.S. Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasure Enterprise (PHEMCE).  This initiative is directed toward bioterror, pandemic threats and other pathogens that are not well addressed with traditional drug or vaccine therapies.

A little more than a decade ago, we were invited to attend an international scientific symposium hosted by the National Center for Biodefense. At the time, our Hemopurifier® was still a development-stage vision. Regardless, the keynote speaker, who formerly led the Soviet Union's biological weapons program, emphasized our approach to be the only way to counter the breadth of viruses that could emerge naturally through mother nature or be created by man as agents of bioterror.

We never forgot that statement.




About the Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical technology currently being advanced in FDA approved studies as a broad-spectrum treatment countermeasure against infectious viral pathogens.  Named a "Top 25 Invention" and one of the "Eleven Most Remarkable Advances in Healthcare," by TIME Magazine, the Hemopurifier® has previously been administered to individuals infected with Ebola virus, Hepatitis C virus and the Human Immunodeficiency virus, which leads to HIV AIDS.

Beyond human treatment experiences, pre-clinical Hemopurifier® studies have validated the capture of Chikungunya, Dengue, Middle East Respiratory Syndrome Coronavirus, West Nile and Zika virus, as well as Vaccinia and Monkey pox, which serve as models for human Smallpox infection.  Specific to pandemic influenza threats, Aethlon has validated the capture of H5N1 avian flu, H1N1 swine flu, and the reconstructed 1918 influenza virus, which represents a model for the strain of influenza that killed an estimated 50 million victims in 1918 and 1919.

The Hemopurifier has also been demonstrated to capture Cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Herpes Simplex virus 1 (HSV1), which are latent viruses often associated with increased mortality in immune-suppressed sepsis patients.  These pathogens also contribute to organ rejection in transplant patients.  To validate treatment performance, the Hemopurifier is supported by the HP Virus Capture Assay, which quantifies the number of viruses captured within the Hemopurifier and no longer circulating in the patient.

About Aethlon Medical
Aethlon Medical (AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer.  To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.  Aethlon is part of the Russell Microcap® Index.  Additional information can be found online at www.AethlonMedical.com or you can connect with us on Twitter, LinkedIn, Facebook and Google+.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. Factors that may contribute to such differences include, without limitation, the Company's ability to maintain its listing on the Nasdaq Capital Market, or any other national securities exchange, that the Company or its subsidiary will not be able to commercialize its products, that the FDA will not approve the initiation or continuation of the Company's clinical programs or provide market clearance of the Company's products, including any products relating to the Zika or MERS-CoV viruses or relating to sepsis, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in its contract with DARPA, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2016, and in the Company's other filings with the Securities and Exchange Commission. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.

Contacts:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc.
858-489-7800 extension 3300

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: AEMD is a previous showcase company.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.



BioDefenseStocks.com - investing ideas in biodefense stocks

Like Biodefense Stocks? View our Biodefense Stocks Directory